Dae‐Young Kim

3.2k total citations
103 papers, 2.0k citations indexed

About

Dae‐Young Kim is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Dae‐Young Kim has authored 103 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 23 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in Dae‐Young Kim's work include Acute Myeloid Leukemia Research (36 papers), Hematopoietic Stem Cell Transplantation (30 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Dae‐Young Kim is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Hematopoietic Stem Cell Transplantation (30 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Dae‐Young Kim collaborates with scholars based in South Korea, United States and Ethiopia. Dae‐Young Kim's co-authors include Je‐Hwan Lee, Jung‐Hee Lee, Kyoo‐Hyung Lee, Miee Seol, Seongsoo Jang, Chan‐Jeoung Park, Mijin Jeon, Chang‐Ju Kim, Sung-Doo Kim and Young‐Don Joo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Dae‐Young Kim

100 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dae‐Young Kim South Korea 24 1.0k 488 405 388 342 103 2.0k
Carmen Martı́nez Spain 34 1.5k 1.5× 434 0.9× 790 2.0× 881 2.3× 216 0.6× 146 3.1k
Jong Rak Choi South Korea 24 397 0.4× 748 1.5× 115 0.3× 236 0.6× 214 0.6× 213 2.4k
Mitchell A. Olman United States 35 242 0.2× 870 1.8× 308 0.8× 216 0.6× 121 0.4× 68 3.5k
Price Blair United States 13 699 0.7× 258 0.5× 397 1.0× 145 0.4× 74 0.2× 16 1.7k
Yoshihiko Nakamura Japan 29 560 0.5× 994 2.0× 587 1.4× 321 0.8× 165 0.5× 135 3.4k
Rodiça Lenkei Sweden 24 238 0.2× 617 1.3× 823 2.0× 301 0.8× 87 0.3× 57 2.5k
Luca Cimino Italy 34 203 0.2× 268 0.5× 331 0.8× 92 0.2× 125 0.4× 139 3.5k
Guixiu Shi China 28 183 0.2× 759 1.6× 857 2.1× 314 0.8× 101 0.3× 122 2.4k
Laura Gutiérrez Spain 21 482 0.5× 401 0.8× 308 0.8× 167 0.4× 61 0.2× 58 1.5k
A. S. D. Spiers United Kingdom 23 644 0.6× 238 0.5× 231 0.6× 503 1.3× 256 0.7× 93 1.9k

Countries citing papers authored by Dae‐Young Kim

Since Specialization
Citations

This map shows the geographic impact of Dae‐Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae‐Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae‐Young Kim more than expected).

Fields of papers citing papers by Dae‐Young Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae‐Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae‐Young Kim. The network helps show where Dae‐Young Kim may publish in the future.

Co-authorship network of co-authors of Dae‐Young Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dae‐Young Kim. A scholar is included among the top collaborators of Dae‐Young Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae‐Young Kim. Dae‐Young Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Je‐Hwan, Hawk Kim, Hawk Kim, et al.. (2015). A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia. Blood. 126(23). 2535–2535. 2 indexed citations
3.
Lee, Jung‐Hee, Jung‐Hee Lee, Je‐Hwan Lee, et al.. (2015). A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 15(11). 655–663. 3 indexed citations
4.
Park, Han‐Seung, Je‐Hwan Lee, Je‐Hwan Lee, et al.. (2015). Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome. Blood. 126(23). 3826–3826. 1 indexed citations
5.
Cho, Young‐Uk, Mi Hyun Bae, Seongsoo Jang, et al.. (2015). JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis. Journal of Korean Medical Science. 30(7). 882–882. 15 indexed citations
6.
Kim, Kyoung Ha, Dae‐Young Kim, Sung‐Hyun Kim, et al.. (2015). Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group. Blood. 126(23). 5166–5166. 1 indexed citations
7.
Lee, Je‐Hwan, Je‐Hwan Lee, Yunsuk Choi, et al.. (2014). Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndrome. European Journal Of Haematology. 94(6). 546–553. 10 indexed citations
8.
Lee, Je‐Hwan, Yunsuk Choi, Sung-Doo Kim, et al.. (2013). Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome. Annals of Hematology. 92(7). 889–897. 20 indexed citations
9.
Lee, Je‐Hwan, Young‐Don Joo, Hawk Kim, et al.. (2012). Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine. Journal of Clinical Oncology. 31(6). 701–709. 77 indexed citations
10.
11.
Park, So-Youn, Sang‐Oh Lee, Sang‐Ho Choi, et al.. (2012). Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study. Journal of Antimicrobial Chemotherapy. 67(6). 1486–1492. 14 indexed citations
12.
Sung, Yun-Hee, et al.. (2012). Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice. Life Sciences. 91(25-26). 1309–1316. 112 indexed citations
13.
Lee, Je‐Hwan, Je‐Hwan Lee, Young‐Don Joo, et al.. (2012). A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis. Blood. 120(21). 3628–3628. 1 indexed citations
14.
Park, Sungchan, Sungchan Park, Kyung Hyun Moon, et al.. (2012). Needles as Urethral Foreign Body in a Child: Successful Removal Using a New Method With a Laparoscopic Needle Holder. Urology. 81(1). 188–190. 8 indexed citations
15.
Kim, Dae‐Young, et al.. (2011). A Case of Hemophagocytic Syndrome as a Complication of Acute Hepatitis A. The Korean Journal of Internal Medicine. 80. 278–282. 1 indexed citations
16.
Lee, Su Jin, Chul Won Jung, Dae‐Young Kim, et al.. (2011). Retrospective multicenter study on the development of peripheral lymphocytosis following second‐line dasatinib therapy for chronic myeloid leukemia. American Journal of Hematology. 86(4). 346–350. 23 indexed citations
17.
18.
Choi, Yunsuk, Je‐Hwan Lee, Je‐Hwan Lee, et al.. (2009). Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia: Role of the NPM1 Mutations May Be Different in Different Races.. Blood. 114(22). 4684–4684.
19.
Lee, Ho Sup, Je‐Hwan Lee, Eun‐Hye Hur, et al.. (2008). Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics. Leukemia Research. 33(3). 426–433. 7 indexed citations
20.
Lee, Je‐Hwan, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2008). Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia. Leukemia Research. 33(4). 511–517. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Martı́nez Breakdown of academic impact, for papers by Jong Rak Choi Breakdown of academic impact, for papers by Mitchell A. Olman Breakdown of academic impact, for papers by Price Blair Breakdown of academic impact, for papers by Yoshihiko Nakamura Breakdown of academic impact, for papers by Rodiça Lenkei Breakdown of academic impact, for papers by Luca Cimino Breakdown of academic impact, for papers by Guixiu Shi Breakdown of academic impact, for papers by Laura Gutiérrez Breakdown of academic impact, for papers by A. S. D. Spiers
Rankless by CCL
2026